Bioequivalence of mirabegron 50 mg extended release Tablet [Design Issues]

posted by qualityassurance – 2022-08-04 17:47 (572 d 18:46 ago) – Posting: # 23202
Views: 2,321

Dear Ibrahim,

❝ Knowing that I couldn't find an accurate data for intrasubject variability of Mirabegnon.

I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.

Hope it may help other forum members.


Complete thread:

UA Flag
 Admin contact
22,912 posts in 4,806 threads, 1,637 registered users;
34 visitors (0 registered, 34 guests [including 8 identified bots]).
Forum time: 11:33 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz